Halozyme Therapeutics Inc (NASDAQ:HALO) concluded the trading at $48.12 on Friday, November 29, with a fall of -0.73% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $48.47 and 5Y monthly beta
Looking at the stock we see that its previous close was $47.79 and the beta (5Y monthly) reads 1.29 with the day’s price range being $46.27 – $48.1699. The company has a trailing 12-month PE ratio of 15.81. In terms of its 52-week price range,
Halozyme Therapeutics Inc (NASDAQ:HALO) shares, rose in value on Friday, November 22, with the stock price up by 5.70% to the previous day’s close as strong demand from buyers drove the stock to $48.31. Actively observing the price movement in the recent trading, the stock
Halozyme Therapeutics Inc (NASDAQ:HALO) price on Friday, November 15, fall -15.40% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $45.65. A look at the stock’s price movement, the close in the last trading session was $53.96, moving
Halozyme Therapeutics Inc (NASDAQ:HALO) price on current trading day, fall -12.75% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $47.08. A look at the stock’s price movement, the level at last check in today’s session was $53.96,
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
